Bumetanide
- OralBumetanide
- Mechanism of Action
- Inhibits the sodium-potassium-chloride cotransporters in the thick ascending limb of the loop of Henle, normally responsible for 25% of tubular sodium reabsorption. Inhibition results in increased excretion of sodium and, with it, water.
Clinical Use
- Indications
- Adverse Effects